Titre :
  • Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.
Auteur : Fizazi, Karim ; Lipton, Allan ; Mariette, Xavier ; Body, Jean-Jacques ; Rahim, Yasmin ; Gralow, Julie R ; Gao, Guozhi M. ; Wu, Ling ; Sohn, Winnie ; Jun, Susie
Informations sur la publication : Journal of clinical oncology, 27, 10, (page 1564-1571)
Statut de publication : Publié, 2009-04
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Aged
Antibodies, Monoclonal -- pharmacokinetics -- therapeutic use
Antibodies, Monoclonal, Humanized
Bone Density Conservation Agents -- therapeutic use
Bone Neoplasms -- complications -- secondary
Bone Resorption -- chemically induced -- prevention & control
Breast Neoplasms -- pathology
Collagen Type I -- urine
Diphosphonates -- administration & dosage
Female
Humans
Male
Middle Aged
Multiple Myeloma -- pathology
Peptides -- urine
Prostatic Neoplasms -- pathology
RANK Ligand -- antagonists & inhibitors -- pharmacokinetics -- therapeutic use
Note : Clinical Trial, Phase II
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2008.19.2146
info:pii/JCO.2008.19.2146
info:pmid/19237632